O'Reilly EM - Search Results

1

Costs and trends in pancreatic cancer treatment.

O'Neill CB, Atoria CL, O'Reilly EM, LaFemina J, Henman MC, Elkin EB. O'Neill CB, et al. Cancer. 2012 Oct 15;118(20):5132-9. doi: 10.1002/cncr.27490. Epub 2012 Mar 13. Cancer. 2012. PMID: 22415469 Free PMC article.

2

5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. Fata F, et al. Cancer. 1999 Oct 1;86(7):1129-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1129::aid-cncr5>3.0.co;2-4. Cancer. 1999. PMID: 10506695

3

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

4

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

5

Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.

Anderson SE, O'Reilly EM, Kelsen DP, Ilson DH. Anderson SE, et al. Cancer Invest. 2003;21(4):512-6. doi: 10.1081/cnv-120022360. Cancer Invest. 2003. PMID: 14533440 Clinical Trial.

6

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O'Reilly E, Shah MA, Kelsen DP, Schwartz GK. Ku GY, et al. Cancer Chemother Pharmacol. 2008 Oct;62(5):875-80. doi: 10.1007/s00280-008-0677-y. Epub 2008 Feb 13. Cancer Chemother Pharmacol. 2008. PMID: 18270704 Clinical Trial.

7

What is the optimal treatment of localized pancreatic adenocarcinoma?

Duffy A, O'Reilly EM. Duffy A, et al. Oncology (Williston Park). 2008 Oct;22(11):1283-91; discussion 1294, 1296-8. Oncology (Williston Park). 2008. PMID: 18980025 Free article. Review.

8

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

Ku GY, O'Reilly EM, Saltz LB, Schrag D, Maki RG, Kelsen DP, Ilson DH. Ku GY, et al. Cancer Invest. 2009 May;27(4):402-6. doi: 10.1080/07357900802406327. Cancer Invest. 2009. PMID: 19219674 Clinical Trial.

9

Current management of advanced hepatocellular carcinoma.

Abou-Alfa GK, Huitzil-Melendez FD, O'Reilly EM, Saltz LB. Abou-Alfa GK, et al. Gastrointest Cancer Res. 2008 Mar;2(2):64-70. Gastrointest Cancer Res. 2008. PMID: 19259298 Free PMC article.

10

Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.

Duffy A, Capanu M, Allen P, Kurtz R, Olson SH, Ludwig E, Klimstra DS, O'Reilly EM. Duffy A, et al. J Surg Oncol. 2009 Jul 1;100(1):8-12. doi: 10.1002/jso.21292. J Surg Oncol. 2009. PMID: 19384918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters